Does EVEROLIMUS Cause Polyomavirus-associated nephropathy? 247 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 247 reports of Polyomavirus-associated nephropathy have been filed in association with EVEROLIMUS (EVEROLIMUS). This represents 0.6% of all adverse event reports for EVEROLIMUS.
247
Reports of Polyomavirus-associated nephropathy with EVEROLIMUS
0.6%
of all EVEROLIMUS reports
12
Deaths
41
Hospitalizations
How Dangerous Is Polyomavirus-associated nephropathy From EVEROLIMUS?
Of the 247 reports, 12 (4.9%) resulted in death, 41 (16.6%) required hospitalization, and 6 (2.4%) were considered life-threatening.
Is Polyomavirus-associated nephropathy Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for EVEROLIMUS. However, 247 reports have been filed with the FAERS database.
What Other Side Effects Does EVEROLIMUS Cause?
Death (5,090)
Malignant neoplasm progression (3,789)
Diarrhoea (3,061)
Fatigue (2,946)
Stomatitis (2,692)
Nausea (2,079)
Dyspnoea (1,925)
Drug ineffective (1,837)
Pyrexia (1,664)
Decreased appetite (1,633)
What Other Drugs Cause Polyomavirus-associated nephropathy?
TACROLIMUS (1,477)
MYCOPHENOLATE MOFETIL (1,112)
PREDNISONE (666)
METHYLPREDNISOLONE (416)
PREDNISOLONE (402)
BASILIXIMAB (298)
CYCLOSPORINE (246)
MYCOPHENOLIC ACID (238)
RITUXIMAB (236)
SIROLIMUS (161)
Which EVEROLIMUS Alternatives Have Lower Polyomavirus-associated nephropathy Risk?
EVEROLIMUS vs EVOLOCUMAB
EVEROLIMUS vs EXELON
EVEROLIMUS vs EXEMESTANE
EVEROLIMUS vs EXENATIDE
EVEROLIMUS vs EXFORGE